9 products were found matching "Cay14845"!

No results were found for the filter!
4-Aminobenzoic Acid hydrazide
4-Aminobenzoic Acid hydrazide

Item number: Cay14845-1

4-Aminobenzoic acid hydrazide (4-ABAH) is an irreversible inhibitor of myeloperoxidase (MPO, IC50 = 0.3 µM). It reduces the production of hypochlorous acid (HOCl) induced by opsonized zymosan or phorbol 12-myristate 13-acetate (PMA, Cay-10008014) in isolated human neutrophils with IC50 values of 16 and 2.2 µM,...
Keywords: 4-ABAH, Myeloperoxidase Inhibitor 1, NSC 640, 4-amino-benzoic acid, hydrazide
Application: Myeloperoxidase inhibitor
CAS 5351-17-7
MW: 151.2 D
From 52.00€ *
Review
2-methyl-alpha-Pyrrolidinopropiophenone (hydrochloride)
2-methyl-alpha-Pyrrolidinopropiophenone (hydrochloride)

Item number: Cay11484-5

Pyrrolidinophenones (PPPs) are a family of compounds that feature a pyrrolidinyl group affixed to the narcotic cathinone. Many have been identified as components of designer drugs. 2-methyl-alpha-Pyrrolidinopropiophenone (hydrochloride) shares structural features with the stimulant alpha-pyrrolidinopropiophenone and...
Keywords: 2-methyl PPP, 2-methyl-alpha-PPP, 1-(2-methylphenyl)-2-(1-pyrrolidinyl)-1-propanone, monohydrochloride
Application: Analytical reference standard, Shares structural features with the stimulant alpha-PPP
CAS 2749897-10-5
MW: 253.8 D
From 266.00€ *
Review
Sulfaphenazole
Sulfaphenazole

Item number: Cay14844-5

CYP2C9 is a major cytochrome P450 enzyme that is involved in the metabolic clearance of various therapeutic agents. Disruption of this enzyme's activity can lead to adverse drug reactions. Sulfaphenazole is an inhibitor of CYP2C9 (Ki = 0.3 µM) that demonstrates at least 100-fold selectivity over other CYP450...
Keywords: Depocid, Depotsulfonamide, Plisulfan, Raziosulfa, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-benzenesulfonamide
Application: CYP2C9 inhibitor
CAS 526-08-9
MW: 314.4 D
From 158.00€ *
Review
Rocaglamide
Rocaglamide

Item number: Cay14841-5

Rocaglamide is an anti-inflammatory, insecticidal, and anticancer tetrahydrobenzofuran isolated from Aglaia species. It has been shown to inhibit both TNF-alpha and the activation of NF-kappaB in Jurkat T cells with IC50 values in the nanomolar range. At 25 nM, rocaglamide induces apoptosis in various human leukemia...
Keywords: NSC 326408, Roc-A, Rocaglamide A,...
Application: Antiinflammatory, immunosuppressant tetrahydrobenzofuran compound
CAS 84573-16-0
MW: 505.6 D
From 135.00€ *
Review
Galloflavin
Galloflavin

Item number: Cay14846-5

Galloflavin is an inhibitor of both the A and B isoforms of lactate dehydrogenase (Kis = 5.46 and 15.06 µM, respectively). It has been shown to prevent proliferation of many different cancer cell lines in vitro by blocking glycolysis and ATP production.Formal Name:...
Keywords: NSC 107022, 3,8,9,10-tetrahydroxy-pyrano[3,2-c][2]benzopyran-2,6-dione
Application: LDH inhibitor
CAS 568-80-9
MW: 278.2 D
From 50.00€ *
Review
ZCL 278
ZCL 278

Item number: Cay14849-5

ZCL 278 is a cell-permeable inhibitor of Cdc42, a Rho family GTPase. It binds into the surface groove on Cdc42 (Kd = 6.4-11.4 µM), blocking interaction with intersectin (ITSN), a guanine nucleotide exchange factor (GEF). It inhibits Cdc42-mediated microspike formation and neuronal branching in 3T3 fibroblast and...
Keywords: 2-(4-bromo-2-chlorophenoxy)-N-[[[4-[[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl]phenyl]amino]thioxomethyl]-acetamide
Application: Cdc42 inhibitor
CAS 587841-73-4
MW: 584.9 D
From 64.00€ *
Review
SA 57
SA 57

Item number: Cay14848-5

SA 57 is an inhibitor of fatty acid amide hydrolase (FAAH, IC50s = 1.9 and 3.2 nM for hFAAH and mFAAH, respectively), monoacylglycerol lipase (MAGL, IC50s = 1,400 and 410 nM for hMAGL and mMAGL, respectively) and alpha/beta-hydrolase domain-containing protein 6 (mABHD6, IC50 = 850 nM). In vivo, SA 57, at doses >1.25...
Keywords: 4-[2-(4-chlorophenyl)ethyl]-1-piperidinecarboxylic acid-2-(methylamino), 2-oxoethyl ester
Application: FAAH inhibitor
CAS 1346169-63-8
MW: 338.8 D
From 43.00€ *
Review
HKI 357
HKI 357

Item number: Cay14847-5

HKI 357 is an irreversible dual inhibitor of the EGF receptor tyrosine kinases EGFR and HER2 (IC50s = 34 and 33 nM, respectively). It inhibits proliferation of A431, SK-BR-3, and SW620 cancer cell lines (IC50s = 120, 2.5, and 511 nM, respectively). HKI 357 suppresses EGFR autophosphorylation and phosphorylation of...
Keywords: (2E)-N-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
Application: EGFR inhibitor, HER2 inhibitor
CAS 848133-17-5
MW: 574.1 D
From 84.00€ *
Review
tetranor-PGEM
tetranor-PGEM

Item number: Cay14840-25

tetranor-Prostaglandin E metabolite (tetranor-PGEM) is the major urinary metabolite of PGE2 (Cay-14010). Urine levels of tetranor-PGEM are increased in patients with diabetic nephropathy. Increased urine levels are also associated with a higher risk of breast cancer in postmenopausal women with a body mass index...
Keywords: tetranor-Prostaglandin E Metabolite, 9,15-dioxo-11alpha-hydroxy-13,14-dihydro-2,3,4,5-tetranor-prostan-1,20-dioic acid
Application: Bioactive lipid assays
CAS 24769-56-0
MW: 328.4 D
From 179.00€ *
Review